sinc
sever
case
merscov
infect
shown
renal
function
impair
case
requir
renal
replac
therapi
addit
merscov
outbreak
report
hemodialysi
unit
saudi
arabia
therefor
merscov
may
includ
kidney
tropism
dipeptidyl
peptidas
dpp
identifi
function
receptor
merscov
messeng
rna
protein
express
dpp
high
kidney
small
intestin
lung
dpp
present
surfac
human
noncili
bronchial
epitheli
cell
consid
function
receptor
merscov
dpp
one
major
brush
border
membran
protein
kidney
also
present
glomerular
podocyt
capillari
report
natur
cours
merscov
infect
term
renal
complic
scarc
furthermor
previou
research
examin
renal
pathogenesi
merscov
base
renal
patholog
find
aim
identifi
renal
complic
prognosi
korean
patient
merscov
term
acut
kidney
injuri
aki
proteinuria
hematuria
studi
subject
merscov
patient
admit
nation
medic
center
korea
may
juli
follow
patient
expir
discharg
hospit
patient
hospit
neg
pressur
isol
ward
receiv
medic
care
standard
contact
http
airborn
precaut
patient
evalu
manag
accord
gener
guidelin
merscov
patient
blood
pressur
temperatur
respir
rate
puls
rate
monitor
regularli
admiss
perform
bacteri
cultur
studi
blood
urin
sputum
ordinari
bacteria
acidfast
bacteria
stain
cultur
viru
polymeras
chain
reaction
influenza
parainfluenza
rhinoviru
adenoviru
merscov
use
upper
lower
respiratori
specimen
patient
also
underw
serial
chest
xray
test
chest
comput
tomographi
perform
clinic
indic
serial
monitor
laboratori
test
perform
patient
accord
patient
clinic
progress
prescrib
antibiot
antivir
agent
interferonalpha
ribavirin
lopinavirritonavir
direct
physician
review
patient
medic
record
nation
medic
center
hospit
patient
previous
admit
merscov
polymeras
chain
reaction
test
perform
korea
nation
institut
health
merscov
infect
initi
diagnos
accord
criteria
recommend
test
conduct
nation
medic
center
aki
defin
consecut
increas
idm
traceabl
serum
creatinin
scr
greater
mgdl
consecut
decreas
isotop
dilut
mass
spectrometrymodif
diet
renal
diseas
idmsmdrd
estim
glomerular
filtrat
rate
egfr
less
initi
level
observ
period
proteinuria
hematuria
dipstick
test
defin
consecut
result
trace
albumin
blood
observ
period
proteinuria
quantit
evalu
randomli
collect
urin
also
defin
consecut
microalbumin
creatinin
ratio
acr
protein
creatinin
ratio
pcr
valu
mgg
creatinin
cr
conduct
statist
analys
use
spss
softwar
spss
version
chicago
il
usa
use
student
ttest
wilcoxon
signedrank
test
determin
mean
sd
continu
variabl
chisquar
test
categor
variabl
use
mix
model
test
withinand
betweenindividu
differ
repeatedli
measur
idm
traceabl
scr
egfr
chang
use
kaplanmei
surviv
analysi
determin
cumul
surviv
probabl
logrank
test
test
surviv
differ
addit
use
standard
timedepend
multivari
cox
proportionalhazard
regress
analys
base
enter
method
howev
perform
timedepend
multivari
cox
proportionalhazard
regress
analysi
applic
mechan
ventil
continu
renal
replac
therapi
crrt
extracorpor
membran
oxygen
ecmo
show
time
interact
occurr
aki
mortal
consid
p
side
statist
signific
protocol
approv
institut
review
board
nation
medic
center
korea
inform
consent
waiv
conduct
studi
complianc
principl
declar
helsinki
total
patient
analyz
mean
median
follow
durat
symptom
onset
day
respect
mean
age
yr
patient
men
characterist
differ
merscov
patient
south
korea
mean
age
yr
men
releas
data
juli
transmiss
statu
follow
first
patient
second
patient
third
patient
fourth
patient
unknown
patient
mean
initi
idm
traceabl
scr
level
mgdl
mean
initi
egfr
preval
diabet
hypertens
chronic
kidney
diseas
ckd
respect
fourteen
patient
receiv
antivir
treatment
tabl
two
consecut
result
trace
albumin
dipstick
test
occur
observ
period
patient
respect
trace
patient
patient
patient
patient
two
consecut
result
trace
blood
dipstick
test
occur
patient
respect
trace
patient
patient
patient
patient
patient
perform
protein
quantit
randomli
collect
urin
patient
show
random
urin
acr
pcr
mgg
cr
observ
period
two
consecut
result
acr
pcr
valu
mgg
cr
occur
patient
respect
two
consecut
result
acr
pcr
valu
mgg
cr
occur
respect
progress
random
urin
acr
pcr
analyz
patient
present
fig
observ
period
patient
show
aki
accord
criteria
defin
studi
mean
median
durat
occurr
aki
symptom
onset
day
respect
two
consecut
increas
idm
traceabl
scr
greater
mgdl
occur
patient
mean
median
durat
day
respect
two
consecut
decreas
egfr
less
initi
level
occur
patient
mean
median
durat
day
respect
progress
idm
traceabl
scr
egfr
analyz
patient
present
fig
compar
aki
n
aki
n
group
patient
aki
group
older
patient
aki
group
p
initi
idm
traceabl
scr
egfr
differ
two
group
p
respect
progress
valu
two
group
show
statist
signific
time
interact
observ
period
fig
b
preval
diabet
hypertens
ckd
differ
two
group
durat
neg
result
merscov
polymeras
chain
reaction
upper
lower
respiratori
specimen
day
aki
group
day
aki
group
p
random
urin
acr
mg
g
cr
frequent
observ
aki
group
aki
group
p
characterist
two
group
present
tabl
diabet
hypertens
ckd
show
signific
differ
cumul
rate
aki
occurr
logrank
p
respect
presenc
comorbid
show
margin
signific
cumul
rate
aki
occurr
logrank
p
old
age
associ
higher
occurr
aki
univari
analysi
hr
ci
p
factor
includ
sex
diabet
ckd
applic
mechan
ventil
signific
risk
factor
aki
old
age
remain
signific
predictor
occurr
aki
adjust
comorbid
applic
mechan
ventil
tabl
mechan
ventil
appli
patient
patient
underw
crrt
ecmo
appli
patient
five
patient
receiv
mechan
ventil
therapi
receiv
mechan
ventil
crrt
therapi
receiv
mechan
ventil
ecmo
therapi
one
patient
receiv
mechan
ventil
crrt
ecmo
therapi
baselin
characterist
patient
underw
crrt
follow
old
male
diabet
hypertens
ckd
heart
diseas
old
male
ckd
chronic
pulmonari
diseas
chronic
liver
diseas
old
male
diabet
hypertens
heart
diseas
progress
idm
traceabl
scr
egfr
accord
applic
crrt
show
statist
signific
time
interact
observ
period
fig
five
patient
die
septic
shock
progress
multipl
organ
failur
median
durat
death
symptom
onset
among
patient
receiv
mechan
ventil
crrt
therapi
receiv
mechan
ventil
ecmo
therapi
patient
receiv
mechan
ventil
crrt
ecmo
therapi
one
patient
refus
life
extens
therapi
two
patient
receiv
antivir
treatment
wherea
surviv
patient
receiv
antivir
treatment
p
progress
idm
traceabl
scr
egfr
dead
aliv
patient
show
statist
signific
time
interact
fig
f
valu
dead
aliv
patient
aki
group
statist
signific
observ
period
either
fig
h
occurr
aki
show
margin
signific
cumul
rate
mortal
analysi
logrank
p
diabet
occurr
aki
applic
crrt
risk
factor
mortal
perform
univari
analysi
among
patient
analyz
present
studi
show
posit
result
albumin
blood
dipstick
test
patient
show
random
urin
acr
pcr
mgg
cr
moreov
patient
show
aki
mean
median
durat
symptom
onset
day
respect
old
age
predictor
occurr
aki
even
adjust
comorbid
applic
mechan
ventil
mechan
ventil
crrt
ecmo
therapi
appli
patient
respect
total
patient
die
septic
shock
progress
multipl
organ
failur
diabet
occurr
aki
applic
crrt
risk
factor
predict
mortal
univari
analysi
first
case
merscov
infect
progress
impair
renal
function
similar
describ
patient
sever
acut
respiratori
syndrom
sarscov
suggest
direct
infect
renal
tissu
viru
patient
merscov
infect
present
sever
pneumonia
acut
respiratori
distress
syndrom
aki
thereaft
kidney
involv
human
coronaviru
notic
sarscov
epidem
occur
earli
report
analyz
patient
sarscov
show
acut
renal
impair
proteinuria
dipstick
test
acut
respiratori
distress
syndrom
age
signific
risk
factor
acut
renal
impair
acut
renal
impair
ment
independ
risk
factor
predict
mortal
howev
kidney
specimen
autopsi
case
show
viral
inclus
electron
dens
deposit
even
situ
hybrid
fail
demonstr
sarscov
suggest
renal
insult
occur
context
multipl
organ
failur
anoth
report
also
state
decreas
glomerular
filtrat
rate
secondari
hypotens
vasoconstrict
sepsi
howev
anoth
studi
detect
sarscov
distal
convolut
renal
tubul
sarscov
patient
develop
aki
median
durat
day
onset
viral
infect
ie
late
virem
hyperimmun
respons
phase
infect
detect
polymeras
chain
reaction
fragment
coronaviru
urin
sar
patient
second
third
week
viral
infect
impli
possibl
kidney
tropism
coronaviru
unfortun
merscov
polymeras
chain
reaction
urin
perform
one
patient
week
symptom
onset
cohort
ensur
viru
absenc
variou
specimen
neg
conclud
renal
patholog
chang
associ
human
coronaviru
may
caus
directli
cytopath
effect
mediat
viru
replic
well
indirectli
system
toxic
reaction
result
respiratori
failur
harm
immun
respons
cytokin
reaction
induc
viral
infect
organ
tropism
human
coronaviru
primarili
determin
abil
receptor
bind
protein
spike
entri
protein
merscov
cell
surfac
receptor
angiotentin
convert
enzym
function
receptor
sarscov
express
human
kidney
dpp
identifi
function
receptor
merscov
dpp
wide
express
serin
peptidas
exist
surfac
variou
cell
type
express
messeng
rna
protein
high
kidney
dpp
one
major
brush
border
membran
protein
kidney
also
present
glomerular
podocyt
capillari
dpp
present
surfac
human
bronchial
epitheli
cell
previous
costain
merscov
merscov
infect
human
kidney
cell
line
perform
kidney
biopsi
one
patient
evalu
persist
proteinuria
week
symptom
onset
fail
reveal
viru
particl
costain
dpp
compat
ultrastructur
howev
interpret
result
limit
autolysi
tissu
direct
involv
kidney
merscov
could
rule
patient
present
studi
show
aki
higher
aki
incid
sarscov
infect
one
explan
differ
aki
incid
may
differ
criteria
use
defin
aki
studi
aki
defin
scr
elev
least
baselin
valu
admiss
consecut
blood
sampl
mgdl
adopt
definit
present
cohort
aki
occur
patient
still
higher
aki
incid
sarscov
infect
anoth
explan
may
older
age
merscov
patient
present
studi
mean
age
yr
present
cohort
approxim
yr
sarscov
cohort
age
independ
risk
factor
aki
studi
older
age
merscov
patient
might
explain
higher
incid
aki
present
studi
previou
studi
patient
whose
viral
rna
detect
whole
blood
urin
sampl
favor
outcom
patient
show
dissemin
viral
infect
investig
studi
conclud
interferon
mediat
respons
trigger
merscov
might
limit
viral
diseas
lung
prevent
system
dissemin
viremia
decreas
immun
respons
older
patient
may
play
role
higher
occurr
aki
viremia
urinari
viral
excret
though
assess
serial
viral
rna
blood
urin
addit
cohort
central
merscov
design
hospit
rule
patient
cohort
underli
diseas
merscov
patient
korea
incid
aki
occurr
might
overestim
contrari
merscov
patient
underw
crrt
therapi
previou
cohort
cohort
crrt
therapi
appli
patient
differ
incid
patient
requir
renal
replac
therapi
explain
two
reason
previou
cohort
icu
admit
patient
baselin
characterist
two
cohort
quit
differ
preval
diabet
hypertens
renal
diseas
respect
much
higher
cohort
mean
median
durat
aki
occurr
approxim
week
symptom
onset
consist
valu
report
sarscov
one
report
show
merscov
pcr
posit
week
blood
patient
specul
durat
symptom
onset
aki
occurr
coincid
late
virem
hyperimmun
respons
phase
infect
case
sarscov
howev
assess
serial
viremia
cytokin
consider
preval
proteinuria
also
consist
result
previou
sarscov
studi
though
quantit
assess
urinari
protein
excret
perform
studi
highest
mean
level
random
urin
mgg
cr
acr
occur
day
symptom
onset
mgg
cr
pcr
occur
day
symptom
onset
earli
phase
high
albumin
excret
may
relat
fever
system
inflammatori
statu
highlevel
proteinuria
approxim
week
symptom
onset
may
associ
viremia
urinari
viru
excret
similar
occurr
aki
howev
assess
serial
virem
statu
blood
sampl
week
symptom
onset
neg
merscov
polymeras
chain
reaction
detect
rate
sarscov
blood
sampl
second
third
week
viral
infect
direct
involv
kidney
merscov
could
rule
perform
blood
assay
week
symptom
onset
studi
sever
limit
first
loss
data
evalu
renal
complic
consist
institut
hospit
patient
previous
admit
second
receiv
posit
statu
merscov
polymeras
chain
reaction
test
except
ct
valu
therefor
could
assess
correl
viral
load
renal
complic
third
compat
renal
patholog
data
therefor
draw
conclus
direct
effect
viru
renal
complic
conclus
half
patient
present
studi
show
proteinuria
onefourth
patient
develop
aki
incid
aki
uncommon
aki
affect
factor
includ
viru
associ
system
inflamm
hypotens
meticul
evalu
manag
kidney
damag
quantit
assess
proteinuria
frequent
monitor
egfr
earnestli
need
old
age
independ
risk
factor
occurr
aki
diabet
aki
applic
crrt
neg
prognost
indic
surviv
merscov
studi
need
reveal
direct
effect
merscov
renal
complic
